Market Synopsis

According to the MRFR analysis, the global Glycoprotein Market size is predicted to reach USD 5320 Million by the end of the year 2028, by registering a CAGR of 2.6%.

Get Free Sample PDF Brochure @

The growth in the usage of glycoprotein is attributed to the continuous use of these in the medical and pharmaceutical industries as they play an important role in physiological events such as cell-cell recognition, signal transduction, inflammation, and tumorigenesis.Furthermore, the increasing application of glycoprotein for research institutes is expected to further fuel the growth of glycoprotein market during the forecast period.

Regional Analysis

According to the reports, on the basis of region, the Glycoprotein Market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. One of the primary factors driving the growth of the North American market is advancements in pharmaceutical and medical research activities in the area. During the projected period, North America is estimated to have the greatest market share of more than 40%. During the projection period, the European market is predicted to be the fastest expanding. The recent construction of research organizations and healthcare centers is projected to strengthen the region's economy.

In the approaching years, the Asia Pacific region is predicted to have a high consumption level. However, the market in this area has exhibited consistent growth in the past, and this is projected to continue over the projection period. The Latin American region has a relatively modest but quickly increasing pharmaceutical industry is likely to drive market growth in the Glycoprotein Market. Due to the Middle East & Africa region's huge investment and manufacturing potential, this area has invested in its medical and pharmaceuticals sectors over the years which is likely to boost the demand for the glycoprotein function in this region.


By Application

  • Hospital: This segment is expected to dominate the market throughout the forecast period. The application of glycoprotein in medical has helped the manufacturers to make large production over the last couple of years. This segment due to covid-19 is expected to have even more share than the historic period.
  • Research Institutes: This is the fastest growing segment owing to theincreasingfocus of research institutes on creating better binders and protein activity; this is expected to propel the growth of glycoprotein market during the review period.
  • Others: The others segment include pharmaceuticals and food industry.

By Region

  • North America: The largest and fastest-growing regional market.
  • Europe: A well-established medical and pharmaceuticalmarket.
  • Asia-Pacific: Market growth is driven by the demand from medical and research industry.
  • Latin America: Rapid growth ofpharmaceutical manufacturing plants is fueling the demand for glycoprotein in Latin America.
  • Middle East & Africa: Growing demand from the medical industriesand investment in pharmaceutical development of the region is fueling the demand of the glycoprotein in the region. 

By Product Type

  • N-linked: The N-linked segment is expected to be the fastest growing segmentdue to the increasing demand from the research and medical sectors in the coming years. They provide structural components to the cell wall and extracellular matrix, modify protein properties such as stability and solubility, and mediate cell signaling. Therefore, the N-linked market is expected to gain major traction for the global market in the forecast period.
  • O-Linked: The O-linked segment held the largest market share of over 50% in 2020and is expected to dominate the market during the forecast period. This is attributed to the increasing demand for various pharmaceutical applications; for instance, it improves immune response, protects against invading microbes, and facilitates fertilization. Thus, these applications are expected to enable the segment to capture a major market share during the forecast period.

Speak To Analyst @


1 Executive Summary

2 Market Introduction

2.1 Market Definition

2.2 Scope Of The Study

2.3 Assumptions & Limitations

2.4 Market Structure

2.5 Key Takeaways

3 Market Insights

4 Research Methodology

4.1 Research Process

4.2 Primary Research

4.3 Secondary Research

4.4 Market Size Estimation

4.5 Forecast Model


Browse Full Report @

Key Players

  • Sigma
  • Creative Diagnostics
  • R&D Systems
  • Enzo Life Sciences
  • Thermo Fisher Scientific
  • Epitope Diagnostics
  • Creative Biolabs
  • BD Biosciences
  • Shanghai Korain Biotech Co.

Pricing Analysis

In 2020, glycoprotein was priced around USD 123.5 to 134.8 per unit across the globe. In the same year, the price of N-linked varied from USD 118.8 to 127.6 per unit. The price ofglycoprotein is expected to witness a gradual rise with a range from USD 131.8 to 142.6per unit by2028. This change in price is expected to be influenced by the availability and pricing of raw materials and growing demand, which is expected to stream-up during the forecast period.